{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:38:03Z","timestamp":1780677483970,"version":"3.54.1"},"reference-count":73,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,11,15]]},"DOI":"10.18632\/aging.205175","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T22:54:26Z","timestamp":1699052066000},"page":"12225-12250","source":"Crossref","is-referenced-by-count":12,"title":["Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin"],"prefix":"10.18632","volume":"15","author":[{"given":"Yuqi","family":"Xin","sequence":"first","affiliation":[{"name":"Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China"},{"name":"Medical College, Nanchang University, Nanchang, Jiangxi 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China"},{"name":"Medical College, Nanchang University, Nanchang, Jiangxi 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China"},{"name":"Medical College, Nanchang University, Nanchang, Jiangxi 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-019-1320-z","article-title":"The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-\u03b2 on tongue squamous cell carcinoma cells and xenograft model.","volume":"1","author":"Yang","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas.","volume":"51","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Nature"},{"key":"4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3892\/ol.2020.11293","article-title":"Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression.","volume":"1","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"key":"5","doi-asserted-by":"publisher","first-page":"eaay3324","DOI":"10.1126\/sciadv.aay3324","article-title":"YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.","volume":"6","author":"Kiyono","year":"2020","journal-title":"Sci Adv"},{"key":"6","doi-asserted-by":"publisher","first-page":"9075","DOI":"10.3892\/ol.2018.8520","article-title":"CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma.","volume":"1","author":"Zhou","year":"2018","journal-title":"Oncol Lett"},{"key":"7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40902-017-0139-8","article-title":"Analysis of the outcome of young age tongue squamous cell carcinoma.","volume":"3","author":"Choi","year":"2017","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.oraloncology.2018.06.018","article-title":"Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.","volume":"8","author":"Yang","year":"2018","journal-title":"Oral Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fonc.2020.00341","article-title":"Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.","volume":"1","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.oraloncology.2010.02.015","article-title":"Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival.","volume":"4","author":"Warnakulasuriya","year":"2010","journal-title":"Oral Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.oraloncology.2010.11.003","article-title":"Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors.","volume":"4","author":"Shpitzer","year":"2011","journal-title":"Oral Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00432-009-0749-3","article-title":"Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.","volume":"13","author":"Taicher","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1080\/0284186X.2019.1660802","article-title":"Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.","volume":"5","author":"Overgaard","year":"2019","journal-title":"Acta Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1101\/gr.228080.117","article-title":"Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.","volume":"2","author":"Kharchenko","year":"2018","journal-title":"Genome Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"a026583","DOI":"10.1101\/cshperspect.a026583","article-title":"Spatial Heterogeneity in the Tumor Microenvironment.","volume":"6","author":"Yuan","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research.","volume":"4","author":"Villanueva","year":"2014","journal-title":"Cancer Discov"},{"key":"17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-1-4939-7765-9_20","article-title":"Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and Propagation.","volume":"176","author":"MacKeigan","year":"2018","journal-title":"Methods Mol Biol"},{"key":"18","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/annonc\/mdx416","article-title":"Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.","volume":"2","author":"Bedi","year":"2017","journal-title":"Ann Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.biopha.2018.12.010","article-title":"Phytochemicals: Current strategy to sensitize cancer cells to cisplatin.","volume":"11","author":"Feng","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"20","doi-asserted-by":"publisher","first-page":"546439","DOI":"10.3389\/fphar.2020.546439","article-title":"Effects of Selected Nigerian Medicinal Plants on the Viability, Mobility, and Multidrug-Resistant Mechanisms in Liver, Colon, and Skin Cancer Cell Lines.","volume":"1","author":"Prieto","year":"2020","journal-title":"Front Pharmacol"},{"key":"21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.phrs.2016.10.022","article-title":"Phytomedicine-Modulating oxidative stress and the tumor microenvironment for cancer therapy.","volume":"11","author":"Shyur","year":"2016","journal-title":"Pharmacol Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.3389\/fimmu.2018.03102","article-title":"Plumbagin Ameliorates Collagen-Induced Arthritis by Regulating Treg\/Th17 Cell Imbalances and Suppressing Osteoclastogenesis.","volume":"9","author":"Tang","year":"2019","journal-title":"Front Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41419-017-0068-6","article-title":"Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"24","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/carcin\/bgs291","article-title":"Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKC\u03b5, Stat3 and neuroendocrine markers.","volume":"3","author":"Verma","year":"2012","journal-title":"Carcinogenesis"},{"key":"25","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.2147\/DDDT.S89621","article-title":"Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.","volume":"9","author":"Qiu","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/DDDT.S76057","article-title":"Plumbagin induces G2\/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K\/Akt\/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.","volume":"9","author":"Zhou","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"27","doi-asserted-by":"publisher","first-page":"5649174","DOI":"10.1155\/2020\/5649174","article-title":"Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.","volume":"202","author":"Qiu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"28","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3389\/fonc.2020.01479","article-title":"Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma.","volume":"1","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jinorgbio.2018.01.014","article-title":"Europium(III)-doped yttrium vanadate nanoparticles reduce the toxicity of cisplatin.","volume":"18","author":"Tavares","year":"2018","journal-title":"J Inorg Biochem"},{"key":"30","doi-asserted-by":"publisher","first-page":"105656","DOI":"10.1016\/j.phrs.2021.105656","article-title":"Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8T cells.","volume":"16","author":"Ma","year":"2021","journal-title":"Pharmacol Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.12865\/CHSJ.44.03.03","article-title":"Epidemiological and Histopathological Aspects of Tongue Squamous Cell Carcinomas-Retrospective Study.","volume":"4","author":"Dumitrescu","year":"2018","journal-title":"Curr Health Sci J"},{"key":"32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jso.20462","article-title":"Re: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et al.","volume":"9","author":"Lim","year":"2006","journal-title":"J Surg Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3892\/etm.2021.10640","article-title":"Current research developments of patient-derived tumour xenograft models (Review).","volume":"2","author":"Chen","year":"2021","journal-title":"Exp Ther Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/2159-8290.CD-11-0109","article-title":"A molecularly annotated platform of patient-derived xenografts (\"xenopatients\") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.","volume":"1","author":"Muratore","year":"2011","journal-title":"Cancer Discov"},{"key":"35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bjoms.2020.01.028","article-title":"Identification of a potential target for treatment of squamous cell carcinoma of the tongue: follistatin.","volume":"5","author":"Wang","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"key":"36","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","article-title":"Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.","volume":"2","author":"Forastiere","year":"2005","journal-title":"J Clin Oncol"},{"key":"37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.","volume":"1","author":"Schacter","year":"1992","journal-title":"J Clin Oncol"},{"key":"38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s43440-020-00106-1","article-title":"Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.","volume":"7","author":"Sa\u0142at","year":"2020","journal-title":"Pharmacol Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1039\/d0fo00469c","article-title":"Red ginseng protects against cisplatin-induced intestinal toxicity by inhibiting apoptosis and autophagy via the PI3K\/AKT and MAPK signaling pathways.","volume":"1","author":"Li","year":"2020","journal-title":"Food Funct"},{"key":"40","doi-asserted-by":"publisher","first-page":"115018","DOI":"10.1016\/j.taap.2020.115018","article-title":"The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies.","volume":"39","author":"El-Mesery","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"41","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s11033-020-05455-x","article-title":"Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro.","volume":"4","author":"Khuda-Bukhsh","year":"2020","journal-title":"Mol Biol Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects.","volume":"3","author":"B\u00fcsselberg","year":"2011","journal-title":"Cancers (Basel)"},{"key":"43","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","article-title":"Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.","volume":"3","author":"Wang","year":"2013","journal-title":"J Clin Oncol"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188993","article-title":"From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models.","author":"Abdelghany","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"45","doi-asserted-by":"publisher","first-page":"14885","DOI":"10.18632\/oncotarget.3659","article-title":"Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.","volume":"6","author":"Zhong","year":"2015","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"6940953","DOI":"10.1155\/2020\/6940953","article-title":"Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.","volume":"202","author":"Kang","year":"2020","journal-title":"Biomed Res Int"},{"key":"47","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1002\/cam4.1737","article-title":"A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.","volume":"7","author":"Zhao","year":"2018","journal-title":"Cancer Med"},{"key":"48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.","volume":"1","author":"Chiu","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"49","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/1541-7786.MCR-16-0431","article-title":"Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models.","volume":"1","author":"Miller","year":"2017","journal-title":"Mol Cancer Res"},{"key":"50","doi-asserted-by":"publisher","first-page":"5291952","DOI":"10.1155\/2020\/5291952","article-title":"AXL as a Target in Breast Cancer Therapy.","volume":"202","author":"Colavito","year":"2020","journal-title":"J Oncol"},{"key":"51","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1021\/acs.jmedchem.5b01273","article-title":"AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective.","volume":"5","author":"Unciti-Broceta","year":"2016","journal-title":"J Med Chem"},{"key":"52","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3892\/ol.2021.13010","article-title":"Anti-Axl monoclonal antibodies attenuate the migration of MDA-MB-231 breast cancer cells.","volume":"2","author":"Lv","year":"2021","journal-title":"Oncol Lett"},{"key":"53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41065-021-00181-1","article-title":"Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.","volume":"15","author":"Hong","year":"2021","journal-title":"Hereditas"},{"key":"54","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1111\/jcmm.16023","article-title":"Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.","volume":"2","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"55","doi-asserted-by":"publisher","first-page":"300060521990512","DOI":"10.1177\/0300060521990512","article-title":"RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.","volume":"4","author":"Du","year":"2021","journal-title":"J Int Med Res"},{"key":"56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3892\/ol.2021.12912","article-title":"Long non-coding RNA OIP5-AS1 promotes the progression of esophageal cancer by regulating miR-30a\/VOPP1 expression.","volume":"2","author":"Chen","year":"2021","journal-title":"Oncol Lett"},{"key":"57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10238-014-0320-7","article-title":"Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer.","volume":"1","author":"Li","year":"2015","journal-title":"Clin Exp Med"},{"key":"58","doi-asserted-by":"publisher","first-page":"685980","DOI":"10.3389\/fonc.2021.685980","article-title":"Role of NRP1 in Bladder Cancer Pathogenesis and Progression.","volume":"1","author":"Xue","year":"2021","journal-title":"Front Oncol"},{"key":"59","doi-asserted-by":"publisher","first-page":"669285","DOI":"10.3389\/fcell.2021.669285","article-title":"DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41419-020-02979-9","article-title":"DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR.","volume":"1","author":"Qin","year":"2020","journal-title":"Cell Death Dis"},{"key":"61","doi-asserted-by":"publisher","first-page":"104207","DOI":"10.1016\/j.mvr.2021.104207","article-title":"Different effects of anti-VEGF drugs (Ranibizumab, Aflibercept, Conbercept) on autophagy and its effect on neovascularization in RF\/6A cells.","volume":"13","author":"Du","year":"2021","journal-title":"Microvasc Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2020.12.019","article-title":"Autophagy-mediated cytoplasmic accumulation of p53 leads to apoptosis through DRAM-BAX in cadmium-exposed human proximal tubular cells.","volume":"53","author":"Oh","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"63","doi-asserted-by":"publisher","first-page":"631879","DOI":"10.3389\/fphar.2021.631879","article-title":"SARS-CoV-2 Switches 'on' MAPK and NF\u03baB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression.","volume":"1","author":"Halwani","year":"2021","journal-title":"Front Pharmacol"},{"key":"64","doi-asserted-by":"publisher","first-page":"REVIEWS3009","DOI":"10.1186\/gb-2002-3-7-reviews3009","article-title":"MAP kinase phosphatases.","volume":"3","author":"Ashworth","year":"2002","journal-title":"Genome Biol"},{"key":"65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/smim.2000.0219","article-title":"Extracellular signals and scores of phosphatases: all roads lead to MAP kinase.","volume":"1","author":"Mustelin","year":"2000","journal-title":"Semin Immunol"},{"key":"66","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00018-016-2142-0","article-title":"Aquaporin-5: from structure to function and dysfunction in cancer.","volume":"7","author":"Soveral","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.biocel.2016.09.005","article-title":"The role of aquaporin-5 in cancer cell migration: A potential active participant.","volume":"7","author":"Nejsum","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"68","doi-asserted-by":"publisher","first-page":"e12842","DOI":"10.1111\/hel.12842","article-title":"Activation of Aquaporin 5 by carcinogenic Helicobacter pylori infection promotes epithelial-mesenchymal transition via the MEK\/ERK pathway.","volume":"2","author":"Hong","year":"2021","journal-title":"Helicobacter"},{"key":"69","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/1878-0261.12753","article-title":"Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma.","volume":"1","author":"Mikkelsen","year":"2020","journal-title":"Mol Oncol"},{"key":"70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/82_2015_475","article-title":"Assembly and Function of the Precursor B-Cell Receptor.","volume":"39","author":"Jumaa","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2019.05.002","article-title":"Time to recurrence and patient survival in recurrent oral squamous cell carcinoma.","volume":"9","author":"Kreppel","year":"2019","journal-title":"Oral Oncol"},{"key":"72","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.2015.61.1509","article-title":"Immunology and Immunotherapy of Head and Neck Cancer.","volume":"3","author":"Ferris","year":"2015","journal-title":"J Clin Oncol"},{"key":"73","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.ctrv.2020.101977","article-title":"Biomarkers for immunotherapy response in head and neck cancer.","volume":"8","author":"Psyrri","year":"2020","journal-title":"Cancer Treat Rev"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:06:55Z","timestamp":1700510815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":73,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2023,11,15]]}},"alternative-id":["205175","37925175"],"URL":"https:\/\/doi.org\/10.18632\/aging.205175","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}